• KYNAMRO, given as a 200 mg weekly subcutaneous injection, has been approved as an adjunct to lipid-lowering medications and diet to reduce low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (Apo B), total cholesterol (TC), and non-high density lipoprotein-cholesterol (non HDL-C) in patients with homozygous familial hypercholesterolemia (HoFH).

    FORBES: FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia

  • These studies had led to new cholesterol guidelines in the U.S. that suggested lowering low-density lipoprotein (LDL), or bad cholesterol, to extemely low levels.

    FORBES: Cholesterol Study Poses Dangers For Merck

  • The addition of Kynamro helps to reduce low-density lipoprotein-cholesterol (LDL-C), apolipoprotein B, total cholesterol, and non-high density lipoprotein-cholesterol (non HDL-C).

    FORBES: FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia

  • Low-density lipoprotein (LDL) or bad cholesterol levels should be below 100, and high-density lipoprotein (HDL) should measure 35 or above.

    CNN: Beta Carotene

  • The medicine worked incredibly well, lowering low-density lipoprotein (LDL), the bad cholesterol, by 70%.

    FORBES: How A Mourning Entrepreneur And A Dogged Doctor Rescued A Rare Disease Drug

  • "I'm confused, " he says, because reducing low-density lipoprotein (LDL), or bad cholesterol, is such a cornerstone of cardiology.

    FORBES: A Backlash Against Vytorin?

  • But when Zetia was combined with a statin like Lipitor or Zocor, it lowered bad cholesterol, or low-density lipoprotein (LDL), more than anything else out there.

    FORBES: Fix It, Fred

  • Both work by inhibiting an obscure molecule called the cholesterol ester transfer protein (CETP) that works indirectly to prevent HDL from being used to create low-density lipoprotein (LDL), the bad cholesterol.

    FORBES: Magazine Article

  • Zetia (generically known as ezetimibe) lowers low-density lipoprotein (LDL), the bad cholesterol involved in causing heart attacks and strokes, but less so than existing drugs like Lipitor (generically known as atorvastatin), Crestor, from AstraZeneca, or simvastatin.

    FORBES: Merck's Cholesterol Pill Win Is Already Drawing Fire

  • For patients at the highest risk of heart attack, the new guidelines suggest that "bad cholesterol, " or low-density lipoprotein (LDL), be reduced to 70 mg per deciliter--although the new guideline is optional.

    FORBES: Cholesterol Guidelines A Gift For Merck, Pfizer

  • Up until now, evidence for statins has been mainly in people with high "bad" cholesterol, properly known as low-density lipoprotein (LDL).

    FORBES: Another Blow For Schering And Merck

  • Schering and Merck have defended the drugs by pointing to the mountains of evidence that support the idea that lowering low-density lipoprotein, commonly known as LDL or "bad cholesterol, " prevents heart attacks.

    FORBES: Magazine Article

  • Most of the time low-density lipoprotein (LDL), better known as "bad cholesterol, " sits around doing little.

    FORBES: Inflamed Hearts

  • The most common type of cholesterol problem is a high LDL (low density lipoprotein) which is usually best treated with a statin, of which there are at least four on the market.

    CNN: Help me understand my cholesterol drugs

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定